Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Spears, C. Weir, J. Thompson, M. Brannigan, R. Chaudhuri, J. Lafferty, E. Cameron, N. Thomson (Glasgow, United Kingdom). Impact of the trumpet and axial diffusion model on alveolar nitric oxide levels in smokers with asthma. Eur Respir J 2010; 36: Suppl. 54, 1278

Member's Comments

No comment yet.

Related content which might interest you: Axial distribution of nitric oxide airway production in unstable asthma patients Source: Annual Congress 2010 - Lung morbidity on exposure to various agents Year: 2010 Partitioning of alveolar and conducting airway nitric oxide in asthma of different severity Source: Eur Respir J 2004; 24: Suppl. 48, 328s Year: 2004 Measurement of bronchial and alveolar nitric oxide production by multiple exhalation flow rates in children Source: Eur Respir J 2004; 24: Suppl. 48, 328s Year: 2004 Normal values of alveolar nitric oxide concentration and bronchial nitric oxide flux in healthy children measured with multiple exhalation flow rate method Source: Eur Respir J 2004; 24: Suppl. 48, 375s Year: 2004 Evaluation of bronchial and alveolar outputs of nitric oxide in children with allergy and asthma using the multiple exhalation flow technique Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010 Correlation between cold airway hyperresponsiveness and the content of nitric oxide in the exhaled air in patients with bronchial asthma Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms Source: Eur Respir J 2002; 20: 841-845 Year: 2002 Comparison of alveolar nitric oxide concentrations using two different methods for the assessment of small airways inflammation in asthma Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 In current smokers fraction of exhaled nitric oxide is not associated with asthma symptoms Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Extended exhaled nitric oxide measurements at different exhalation flows may differentiate between bronchial airways and alveolar inflammation in patients with asthma and COPD Source: Eur Respir J 2002; 20: Suppl. 38, 174s Year: 2002 Increased bronchial but not alveolar exhaled nitric oxide is associated with snoring Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Changes in nitric oxide production in patients with bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 588s Year: 2007 Self-reported asthma control correlates with fraction of exhaled nitric oxide and lung function Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003 Bronchodilator response and previous lung function decline in relation with exhaled nitric oxide levels in asthma Source: International Congress 2017 – Monitoring novel biomarkers in asthma Year: 2017 Features of production nitric oxide at patients with a bronchial asthma Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Increased nitric oxide production by neutrophils in bronchial asthma Source: Eur Respir J 2001; 17: 868-871 Year: 2001 Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral versus central airways Source: Eur Respir J 2003; 22: Suppl. 45, 449s Year: 2003 Combined effects of type 2 inflammation and lung function on exhaled nitric oxide ability to reflect asthma control Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019